Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BMI-stratified phenotypes of polycystic ovary syndrome: advances in gut microbiota research and personalized management strategies.

Frontiers in endocrinology - 1 Jan 2026

Su Bisha, Cao Yining, Ma Lin, Huang Jian

Abstract excerpt

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine-metabolic disorder affecting 11%-13% of women of reproductive age. Based on body mass index (BMI), patients can be phenotypically classified into obese and non-obese subgroups: the obese PCOS is characterized by insulin resistance, hyperandrogenemia, and metabolic syndrome, with more pronounced metabolic risks; non-obese PCOS primarily manifests as...

Topics

Join the communities discussing this publication.

Body Mass Index
Dysbiosis
Gastrointestinal Microbiome
Obesity
Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Polycystic Ovary Syndrome

Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 41727680
DOI: 10.3389/fendo.2026.1734041
PMCID: PMC12920190

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BMI-stratified phenotypes of polycystic ovary syndrome: advances in gut microbiota research and personalized management strategies.PMID 41727680Read ↗

Polycystic Ovary Syndrome: Etiology, Current Management, and Future TherapeuticsSemantic proximity Read ↗

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applicationsSemantic proximity Read ↗

The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A ReviewSemantic proximity Read ↗

Polycystic ovary syndrome and insulin resistance: A focus on pathogenesis, risk factors, and therapeutic strategies.Semantic proximity Read ↗

A New Approach to Polycystic Ovary Syndrome: The Gut MicrobiotaSemantic proximity Read ↗

Polycystic Ovary Syndrome: Challenges and Possible SolutionsSemantic proximity Read ↗

Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic StrategySemantic proximity Read ↗

The impact of the gut microbiota on the reproductive and metabolic endocrine systemSemantic proximity Read ↗

Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patientsSemantic proximity Read ↗

Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype.Semantic proximity Read ↗

Gut microbiota and risk of polycystic ovary syndrome: Insights from Mendelian randomizationSemantic proximity Read ↗

Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.